Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
The biggest names behind biotech stocks are investing richly in artificial intelligence with the goal of speeding up drug development. The post Making Drugs With AI: Biopharma Giants Gear Up For New Arena appeared first on Investor’s Business Daily.
Sales of Kiniksa Pharmaceuticals’ biggest product, Arcalyst, are expected to begin declining in 2030. But the company has a plan. The post Kiniksa’s Sales Are Expected To Decline — Why That’s All According To Plan appeared first on Investor’s Business Daily.
Eli Lilly stock broke out of a flat base and reached a record high. Its Mounjaro drug sales surged 91% in the second quarter. The post Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The…
After skyrocketing 1,027% off a low, Relay Therapeutics taps AI and machine learning to fuel more gains. The post This ‘Dynamo’ Biotech Puts AI-Fueled Breakout In Motion appeared first on Investor’s Business Daily.
MarketSurge data shows short interest in Moderna was 6.9 times the stock’s daily average share turnover. The post Stock Market Rises, But Sellers Hit Some Leaders; Trump Move Shoots Holes Through This Industry appeared first on Investor’s Business Daily.
The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs. The post Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market appeared first on Investor’s Business Daily.
Moderna skyrocketed and Merck jumped on strong late-stage trial results for their cancer vaccine in melanoma patients Wednesday. The post Moderna Skyrockets Over 60%, Merck Jumps On Late-Stage Cancer Vaccine Trial Win appeared first on Investor’s Business Daily.
Eli Lilly is Tuesday’s IBD Stock Of The Day. Shares are staring down two potential entries as the weight-loss kingpin gains on Novo Nordisk. The post Eli Lilly, Stock Of The Day, Is Erasing Novo’s Early Lead In Weight-Loss Pills…
Amylyx stock skyrocketed Tuesday after its GLP-1 drug reduced hypoglycemia in patients who’ve undergone bariatric surgery. The post A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High. appeared first on Investor’s Business Daily.
Argenx stock surged Monday after its blockbuster autoimmune drug, Vyvgart, showed promise in patients with inflammatory diseases. The post Argenx’s Vyvgart Scored Another Win — Why Shares Bolted Higher appeared first on Investor’s Business Daily.
